XML 37 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
January2024 P I P E Transaction
At The Market Sales Agreement
Common Stock
Common Stock
January2024 P I P E Transaction
Common Stock
At The Market Sales Agreement
Additional Paid-In Capital
Additional Paid-In Capital
January2024 P I P E Transaction
Additional Paid-In Capital
At The Market Sales Agreement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022       39,307,286              
Beginning balance at Dec. 31, 2022 $ 113,684     $ 4     $ 427,925     $ 3,035 $ (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (25,272)                   (25,272)
Stock-based compensation 1,979           1,979        
Foreign currency translation 776                 776  
Shares issued from exercise of pre-funded warrants (in shares)       5,096,552              
Shares issued from exercise of pre-funded warrants 51           51        
Ending balance (in shares) at Mar. 31, 2023       44,403,838              
Ending balance at Mar. 31, 2023 91,218     $ 4     429,955     3,811 (342,552)
Beginning balance (in shares) at Dec. 31, 2022       39,307,286              
Beginning balance at Dec. 31, 2022 113,684     $ 4     427,925     3,035 (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (72,040)                    
Foreign currency translation 870                    
Ending balance (in shares) at Sep. 30, 2023       44,595,383              
Ending balance at Sep. 30, 2023 48,407     $ 4     433,818     3,905 (389,320)
Beginning balance (in shares) at Mar. 31, 2023       44,403,838              
Beginning balance at Mar. 31, 2023 91,218     $ 4     429,955     3,811 (342,552)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (23,999)                   (23,999)
Stock-based compensation 1,798           1,798        
Foreign currency translation 171                 171  
Shares issued in connection with the Company's Employee Stock Purchase Plan (in shares)       84,533              
Shares issued in connection with the Company's Employee Stock Purchase Plan 96           96        
Ending balance (in shares) at Jun. 30, 2023       44,488,371              
Ending balance at Jun. 30, 2023 69,284     $ 4     431,849     3,982 (366,551)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (22,769)                   (22,769)
Stock-based compensation 1,687           1,687        
Foreign currency translation (77)                 (77)  
Issuance of common stock (in shares)           107,012          
Issuance of common stock     $ 282           $ 282    
Ending balance (in shares) at Sep. 30, 2023       44,595,383              
Ending balance at Sep. 30, 2023 $ 48,407     $ 4     433,818     3,905 (389,320)
Beginning balance (in shares) at Dec. 31, 2023 45,177,730     45,177,730              
Beginning balance at Dec. 31, 2023 $ 28,931     $ 4     436,060     3,759 (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (29,584)                   (29,584)
Stock-based compensation 2,750           2,750        
Foreign currency translation 528                 528  
Issuance of common stock (in shares)         44,751,286 150,000          
Issuance of common stock   $ 52,364 $ 191   $ 4     $ 52,360 $ 191    
Conversion of tranche rights liability to equity 28,396           28,396        
Ending balance (in shares) at Mar. 31, 2024       90,079,016              
Ending balance at Mar. 31, 2024 $ 83,576     $ 8     519,757     4,287 (440,476)
Beginning balance (in shares) at Dec. 31, 2023 45,177,730     45,177,730              
Beginning balance at Dec. 31, 2023 $ 28,931     $ 4     436,060     3,759 (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (75,332)                    
Foreign currency translation $ 127                    
Ending balance (in shares) at Sep. 30, 2024 90,079,016     90,079,016              
Ending balance at Sep. 30, 2024 $ 41,219     $ 8     523,549     3,886 (486,224)
Beginning balance (in shares) at Mar. 31, 2024       90,079,016              
Beginning balance at Mar. 31, 2024 83,576     $ 8     519,757     4,287 (440,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (21,380)                   (21,380)
Stock-based compensation 1,882           1,882        
Foreign currency translation (505)                 (505)  
Ending balance (in shares) at Jun. 30, 2024       90,079,016              
Ending balance at Jun. 30, 2024 63,573     $ 8     521,639     3,782 (461,856)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (24,368)                   (24,368)
Stock-based compensation 1,910           1,910        
Foreign currency translation $ 104                 104  
Ending balance (in shares) at Sep. 30, 2024 90,079,016     90,079,016              
Ending balance at Sep. 30, 2024 $ 41,219     $ 8     $ 523,549     $ 3,886 $ (486,224)